Banque Cantonale Vaudoise
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1793755
LAUSANNE, V8
Position in REGN
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$1,522,100
+$625,188 QoQ
Shares Held
1,970
+69.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Banque Cantonale Vaudoise holds $13,170,474 across 21 Biotechnology names. REGN ranks #3 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,927 | $3,986,262 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,978 | $1,977,940 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,970 | $1,522,100 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
16,000 | $903,840 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
17,463 | $830,714 | |
| 6 | INSM |
INSMED Inc
|
3,923 | $641,488 | |
| 7 | SMMT |
Summit Therapeutics Inc.
|
23,916 | $453,447 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
862 | $451,231 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,522,100 | 1,970 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $896,912 | 1,162 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $843,405 | 1,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $606,375 | 1,155 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,632,508 | 2,574 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $858,863 | 817 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,511,381 | 1,438 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $4,488,090 | 4,663 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $3,070,501 | 3,496 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $3,207,898 | 3,898 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,578,121 | 3,588 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,156,800 | 6,276 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,880,202 | 2,606 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,213,578 | 4,665 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $2,763,532 | 4,675 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,159,514 | 3,092 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $3,263,063 | 5,167 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,156,256 | 3,563 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,112,398 | 3,782 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,725,541 | 3,647 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,556,580 | 3,222 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,044,316 | 3,652 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $3,236,743 | 5,190 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $1,218,283 | 2,495 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||